Company: CI
Filing Date: 2025-09-04
Form Type: 424B5
Source: 0001140361-25-033868
Chunk: 47

Company: Cigna Group
Filing Date: 2025-09-04
Form: 424B5
Chunk 47
---
 may determine at the time of the offering. We will provide the specific terms of the securities in supplements to this prospectus.

The debt securities, preferred stock, warrants and purchase contracts may be convertible into or exercisable or exchangeable for common or preferred stock or other securities of the Company or debt or equity securities of one or more other entities. These securities may also be sold by one or more selling security holders to be named in a prospectus supplement. You should read this prospectus and any related prospectus supplement carefully before you invest in our securities.

Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “CI”. The last reported sale price of our common stock on the NYSE on August 29, 2025 was $300.87 per share.

We or any selling security holders may offer and sell these securities to or through one or more underwriters, dealers or agents, or directly to purchasers, on a continuous or delayed basis. If underwriters, dealers or agents are used to sell the securities, we will name them and describe their compensation in a prospectus supplement or free writing prospectus.

Investing in these securities involves certain risks. You should carefully consider the risk factors included in our periodic reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, and incorporated by reference herein before you invest in any of our securities. We may also include specific risk factors in an applicable prospectus supplement under the heading “Risk Factors.”

Neither the Securities and Exchange Commission nor any state securities regulator has approved or disapproved of these securities, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.**

#### The date of this prospectus is September 2, 2025.
TABLE OF CONTENTS

TABLE OF CONTENTS

|                                                                       |     | Page |
| About This Prospectus                                                 |     |    i |
| Cautionary Note Regarding Forward-Looking Statements and Risk Factors |     |   ii |
| Trademarks and Service Marks                                          |     |  iii |
| Where You Can Find More Information                                   |     |  iii |
| Incorporation of Certain Information by Reference                     |     |   iv |
| The Cigna Group                                                       |     |    1 |
| Use of Proceeds                                                       |     |    2 |
| Description of Debt Securities                                        |     |    3 |
| Form of Debt Securities                                               |     |   10 |
| Description of